Ascentage Pharma B-Cell Cancer Candidate Receives FDA IND Clearance
By Karen Roman Ascentage Pharma Group Internat (Nasdaq: AAPG) said its treatment candidate for B-cell...

By Karen Roman Ascentage Pharma Group Internat (Nasdaq: AAPG) said its treatment candidate for B-cell...
By Karen Roman Biopharmaceutical company Medera Inc. said it completed patient enrollment for Cohort B...
By Karen Roman SkylineDx said it published new peer-reviewed data where its Merlin CP-GEP Test...
By Karen Roman Sequana Medical NV (BRU: SEQUA.BR) said it successfully implanted the alfapump device...
By Daniella Parra March Bio is developing MB-105, a first-in-class autologous CD5-targeted CAR-T cell therapy for...
Exec Edge hosted a fireside chat on Dec. 8 from the Nasdaq Marketsite with Chris...
IPO Edge hosted a fireside chat on Dec. 8 from the Nasdaq Marketsite with Christer...
By Daniella Parra ReAlta Life Sciences’ Pegtarazimod demonstrated significant clinical improvement and reduction in inflammatory...
By Karen Roman March Biosciences said it appointed Gurpreet Ratra, Ph.D., as Chief Business Officer. Dr....
By Karen Roman Acumen Pharmaceuticals, Inc. (Nasdaq: ABOS) said it is presenting new research at...